Publicacións en colaboración con investigadores/as de Heidelberg University (45)

2024

  1. A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey

    European Journal of Surgical Oncology, Vol. 50, Núm. 10

  2. A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function

    European Journal of Heart Failure, Vol. 26, Núm. 4, pp. 707-729

2023

  1. Best original research presented at the 24th European Congress on Gynaecological Oncology—Best of ESGO 2023

    International Journal of Gynecological Cancer, Vol. 34, Núm. 4, pp. 610-618

  2. Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results

    EJHAEM, Vol. 4, Núm. 4, pp. 1117-1131

  3. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease

    Gut, Vol. 71, Núm. 9, pp. 1856-1866

  2. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement

    Obesity Facts, Vol. 15, Núm. 3, pp. 321-335

  3. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement

    Clinical Nutrition, Vol. 41, Núm. 4, pp. 990-1000

  4. IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results From a Phase I/II Study

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S387

  5. Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy

    Breast, Vol. 63, pp. 123-139

  6. Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study

    The Lancet Oncology, Vol. 23, Núm. 8, pp. 1055-1065

  7. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey

    International Journal of Geriatric Psychiatry, Vol. 36, Núm. 2, pp. 324-333

  2. Erratum: Gaia Early Data Release 3: Summary of the contents and survey properties (Astronomy and Astrophysics DOI: 10.1051/0004-6361/202039657)

    Astronomy and Astrophysics

  3. Gaia Early Data Release 3: Acceleration of the Solar System from Gaia astrometry

    Astronomy and Astrophysics, Vol. 649

  4. Gaia Early Data Release 3: Structure and properties of the Magellanic Clouds

    Astronomy and Astrophysics, Vol. 649

  5. Gaia Early Data Release 3: Summary of the contents and survey properties

    Astronomy and Astrophysics, Vol. 649

  6. Gaia Early Data Release 3: The Gaia Catalogue of Nearby Stars

    Astronomy and Astrophysics, Vol. 649

  7. Gaia Early Data Release 3: The Galactic anticentre

    Astronomy and Astrophysics, Vol. 649

  8. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382